Letter by David et al regarding article, "periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: Results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial"

Circulation

Volumn 127, Issue 11, 2013, Pages

  David, Jean Stephane ^a   Piriou, Vincent ^a   Albaladejo, Pierre ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; DABIGATRAN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PROTOCOL; DRUG WITHDRAWAL; EMERGENCY SURGERY; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LETTER; PEROPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; THERAPY DELAY; THROMBOEMBOLISM;

ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HEMORRHAGE; HUMANS; MALE; THROMBOEMBOLISM; WARFARIN;

EID: 84875198989     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.133041     Document Type: Letter

References (5)

1. Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Heidbuchle H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation. 2012;126:343-348.
2. Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res. 2010;126:e167-e174.
3. Tafur AJ, McBane R 2nd, Wysokinski WE, Litin S, Daniels P, Slusser J, Hodge D, Beckman MG, Heit JA. Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost. 2012;10:261-267.
4. Vigué B. Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice. Crit Care. 2009;13:209.
5. Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol. 2012;59:1168-1174.